Matinas Biopharma (NYSEAMERICAN:MTNB – Get Free Report) released its earnings results on Monday. The company reported ($9.35) earnings per share for the quarter, FiscalAI reports.
Matinas Biopharma Price Performance
Shares of MTNB stock opened at $0.86 on Wednesday. The business has a 50-day moving average of $2.08 and a 200 day moving average of $6.45. Matinas Biopharma has a 1-year low of $0.81 and a 1-year high of $18.02. The stock has a market capitalization of $838,586.00, a PE ratio of -0.05 and a beta of 2.24.
About Matinas Biopharma
Read More
- Five stocks we like better than Matinas Biopharma
- AMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?
- 3 Stocks Flashing Buy Signals With Historical Win Rates Above 85% After the Sell-Off
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
Receive News & Ratings for Matinas Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
